Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 223,000 shares, an increase of 76.4% from the October 31st total of 126,400 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average daily trading […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 133,100 shares, a decrease of 31.3% from the August 31st total of 193,800 shares. Based on an average daily volume of 56,400 shares, the short-interest ratio […]
Cyclo Therapeutics, Inc (NASDAQ:CYTH) Sees Large Decline in Short Interest kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Axcella Health (NASDAQ:AXLA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, risk, earnings and valuation. Earnings & Valuation This table compares Cyclo […]
Contrasting Adaptimmune Therapeutics (NASDAQ:ADAP) & Cyclo Therapeutics (NASDAQ:CYTH) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.